| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Prevention |
Departments of 1 Epidemiology and 2 Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas and 3 School of Public Health, Yale University School of Medicine, New Haven, Connecticut
Requests for reprints: Xifeng Wu, Department of Epidemiology, Unit 1340, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-745-2485; Fax: 713-792-4657; E-mail: xwu{at}mdanderson.org.
Key Words: microRNA • polymorphism • bladder cancer
MicroRNAs (miRNA) are small noncoding RNA molecules involved in a diversity of cellular functions. Although it has been reported that global suppression of the miRNA biogenesis pathway leads to enhanced tumorigenesis, the effect of common genetic variants of miRNA-related genes on cancer predisposition is unclear. To better understand this effect, we genotyped 41 single-nucleotide polymorphisms (SNP) from 24 miRNA-related genes in a case-control study conducted in 746 Caucasian patients with bladder cancer and 746 matched controls. The homozygous variant genotype of a nonsynonymous SNP in the GEMIN3 gene (rs197414) was associated with a significantly increased bladder cancer risk [odds ratios (OR), 2.40; 95% confidence interval (95% CI), 1.04–5.56]. Several additional miRNA-related SNPs were also identified that showed a borderline significant association with bladder cancer risk. Haplotype analysis indicated that a common haplotype of the GEMIN4 gene was associated with a significantly increased bladder cancer risk with an OR of 1.25 (95% CI, 1.01–1.54). To assess the aggregate effects of the promising SNPs, we performed a combined unfavorable genotype analysis that included all SNPs showing at least a borderline statistical significance. We found that, compared with the low-risk reference group with less than two unfavorable genotypes, the medium-risk group with two unfavorable genotypes exhibited a 1.29-fold (0.92–1.81) increased risk whereas the high-risk group with more than two unfavorable genotypes exhibited a 1.92-fold (1.36–2.71) increased risk (Ptrend < 0.0001). Overall, this is the first epidemiologic study showing that miRNA-related genetic variants may affect bladder cancer risk individually and jointly. [Cancer Res 2008;68(7):2530–7]
This article has been cited by other articles:
|
|
 |
|
  S. Hiard, C. Charlier, W. Coppieters, M. Georges, and D. Baurain Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates Nucleic Acids Res., November 11, 2009; (2009) gkp926v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kato, L. Arce, and R. Natarajan MicroRNAs and Their Role in Progressive Kidney Diseases Clin. J. Am. Soc. Nephrol., July 1, 2009; 4(7): 1255 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fabbri, N. Valeri, and G. A. Calin MicroRNAs and genomic variations: from Proteus tricks to Prometheus gift Carcinogenesis, June 1, 2009; 30(6): 912 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Horikawa, C. G. Wood, H. Yang, H. Zhao, Y. Ye, J. Gu, J. Lin, T. Habuchi, and X. Wu Single Nucleotide Polymorphisms of microRNA Machinery Genes Modify the Risk of Renal Cell Carcinoma Clin. Cancer Res., December 1, 2008; 14(23): 7956 - 7962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ye, K. K. Wang, J. Gu, H. Yang, J. Lin, J. A. Ajani, and X. Wu Genetic Variations in MicroRNA-Related Genes Are Novel Susceptibility Loci for Esophageal Cancer Risk Cancer Prevention Research, November 1, 2008; 1(6): 460 - 469. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
